MENU
+Compare
ABEO
Stock ticker: NASDAQ
AS OF
Aug 15, 04:59 PM (EDT)
Price
$7.12
Change
-$0.11 (-1.52%)
Capitalization
369.86M

ABEO Abeona Therapeutics Forecast, Technical & Fundamental Analysis

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABEO with price predictions
Aug 14, 2025

Momentum Indicator for ABEO turns positive, indicating new upward trend

ABEO saw its Momentum Indicator move above the 0 level on August 14, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where ABEO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ABEO just turned positive on August 14, 2025. Looking at past instances where ABEO's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

ABEO moved above its 50-day moving average on July 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ABEO crossed bullishly above the 50-day moving average on July 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ABEO advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 134 cases where ABEO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABEO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ABEO broke above its upper Bollinger Band on August 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.937) is normal, around the industry mean (19.052). P/E Ratio (0.000) is within average values for comparable stocks, (52.768). ABEO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.921). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (30.303) is also within normal values, averaging (291.723).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABEO is expected to report earnings to fall 91.91% to 13 cents per share on November 17

Abeona Therapeutics ABEO Stock Earnings Reports
Q3'25
Est.
$0.14
Q2'25
Beat
by $2.09
Q1'25
Beat
by $0.13
Q4'24
Beat
by $0.85
Q3'24
Missed
by $0.24
The last earnings report on August 14 showed earnings per share of $1.71, beating the estimate of -37 cents. With 673.80K shares outstanding, the current market capitalization sits at 369.86M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
6555 Carnegie Avenue
Phone
+1 646 813-4701
Employees
84
Web
https://www.abeonatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CINGF0.07N/A
+3.70%
Coinsilium Group Ltd.
CPCAY6.800.21
+3.22%
Cathay Pacific Airways, Ltd.
AZNCF155.751.45
+0.94%
AstraZeneca Plc
LNDAF1.58N/A
N/A
LINEA DIRECTA ASEGURADORA SA
AAWH0.64-0.01
-0.79%
Ascend Wellness Holdings, Inc.

ABEO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABEO has been loosely correlated with ZYME. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABEO jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
+10.21%
ZYME - ABEO
48%
Loosely correlated
+2.58%
RARE - ABEO
45%
Loosely correlated
+0.14%
CRNX - ABEO
45%
Loosely correlated
-1.33%
ERAS - ABEO
45%
Loosely correlated
-3.09%
ELVN - ABEO
42%
Loosely correlated
-1.08%
More